Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ejlkCfbwocfarRcZdRqh

February 5, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
 
  • Study: PET/CT with 11C-PIB may identify cardiac amyloidosis
    PET/CT imaging with 11C-PIB detected amyloid accumulation in patients with cardiac amyloidosis, according to a study published in the Journal of Nuclear Medicine. Researchers also employed 11C-acetate to determine myocardial blood flow. "This study emphasizes the strength of molecular imaging for detecting an underlying and significant molecular aberration in a disease that presents with unspecific symptoms and signs," said lead researcher Gunnar Antoni from the PET Centre at Uppsala University Hospital in Sweden. Diagnostic Imaging (2/4) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
The MEDRAD™ Intego™ is making personalized PET practical.
Clinicians are able to set weight-based dosing formulas to determine and administer an accurate, personalized dose for each unique patient. Precise delivery and dose-on-demand capabilities enable lower patient dosing, leading to better patient care. To learn more, click here.
  Clinical News & Research 
  • Trial to test Lymphoseek in patients with colorectal cancer
    Navidea Biopharmaceuticals has formed a partnership with Maimonides Medical Center in New York that will focus on an open-label clinical trial involving Lymphoseek, a radiopharmaceutical designed to stage cancers by pinpointing the lymph nodes that drain from a primary tumor. The trial will test the agent in patients with colorectal cancer and is set to start in the first half of the year. AuntMinnie.com (free registration) (2/4) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  News from the Field 
  • Clinicians see more value in the term "precision medicine"
    Some clinicians and biomedical researchers have taken to using the term "precision medicine" instead of the more frequently used "personalized medicine" to describe treatment based on a patient's genetic profile. Proponents, including the National Research Council, say "personalized" implies the creation of unique drugs or devices to treat a single person, whereas "precision" implies targeted treatment based on the biology or prognosis of a subpopulation's disease. Clinicians are integral to the success of personalized medicine, and if they prefer "precision," a vocabulary change is a small price to pay, writes Luke Timmerman. Xconomy (2/4) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • HHS: Cutting outdated Medicare rules could save $676M yearly
    HHS proposed eliminating some outdated Medicare regulations to save health care providers and hospitals about $3.4 billion in five years, or $676 million a year. "By eliminating outdated or overly burdensome requirements, hospitals and health care professionals can focus on treating patients," HHS Secretary Kathleen Sebelius said. Reuters (2/4) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  From SNMMI 
  • SNMMI's 2013 Annual Meeting: Essential by design
    With more than 100 CE sessions available, the latest research across all modalities, presentations from leading experts, countless networking opportunities and one of the largest exhibit halls in the profession, the SNMMI Annual Meeting is your one stop for learning and networking. Register today and be part of the premier educational and scientific event in nuclear and molecular imaging. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
Failure changes for the better, success for the worse."
--Seneca the Younger,
Roman philosopher, statesman and playwright


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information